Clinical trial reportDiabetes, obesity & metabolismPublished
No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled, cross-over trial (ENERGIZE)
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Institutions
- Perelman School of Medicine, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Diabetes, obesity & metabolism
- Published
- Topic
- Clinical care
- Subject terms
- Liver; Humans; Diabetes Mellitus, Type 2; Body Weight; Benzhydryl Compounds; Glucosides; Blood Glucose; Hypoglycemic Agents; Treatment Outcome; Cross-Over Studies; Double-Blind Method; Energy Metabolism
- PubMed ID
- 37667658
- Open access
- Yes, open
- Added to directory
- Source checked